AnalystsHartaj SinghHartaj Singh's Stock Forecasts
AnalystsHartaj Singh
Sectors:
Industries:
Analyst Ranking
Top 27%
#1202 out of 4554 analysts
Average Return
+2.14%
Win Rate
46%32 out of 69
Risk vs Reward
Poor
Good
Hartaj Singh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +329.18% | $37.25 | $159.87 | 2020-04-14 - 2021-04-15 | Buy |
Icosavax IncICVX | +177.86% | $5.51 | $15.31 | 2023-04-24 - 2024-02-16 | Buy |
Moderna IncMRNA | +162.71% | $157.48 | $413.72 | 2021-01-31 - 2021-08-06 | Buy |
Astria Therapeutics IncATXS | +134.74% | $4.49 | $10.54 | 2023-11-14 - 2024-04-18 | Buy |
Harpoon Therapeutics IncHARP | +118.10% | $10.55 | $23.01 | 2024-01-04 - 2024-03-08 | Buy |
Hartaj Singh Analyst Color
Get additional color on Hartaj Singh's coverage of popular stocks
Hartaj Singh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viracta Therapeutics IncVIRX | 2 | Buy | $13.00 | +1,330.14% | Maintains | 2 days ago |
Vertex Pharmaceuticals IncVRTX | 8 | Buy | $500.00 | +27.07% | Maintains | 4 days ago |
Biomea Fusion IncBMEA | 4 | Buy | $70.00 | +527.24% | Maintains | 16 days ago |
Inovio Pharmaceuticals IncINO | 3 | Buy | $40.00 | +292.16% | Maintains | a month ago |
Gilead Sciences IncGILD | 1 | Buy | $105.00 | +58.71% | Maintains | 2 months ago |
Entrada Therapeutics IncTRDA | 1 | Buy | $22.00 | +84.72% | Initiates Coverage On | 3 months ago |
Harpoon Therapeutics IncHARP | 1 | Buy | $23.00 | -0.04% | Initiates Coverage On | 3 months ago |
Moderna IncMRNA | 4 | Buy | $142.00 | +39.22% | Upgrades | 4 months ago |
Astria Therapeutics IncATXS | 4 | Buy | $25.00 | +137.19% | Maintains | 5 months ago |
Icosavax IncICVX | 3 | Buy | $25.00 | +63.29% | Reiterates | 7 months ago |
Opthea LtdOPT | 3 | Buy | $16.00 | +370.59% | Maintains | 7 months ago |
Regeneron Pharmaceuticals IncREGN | 5 | Buy | $1,050.00 | +17.45% | Maintains | 8 months ago |
Spruce Biosciences IncSPRB | 4 | Buy | $7.00 | +898.57% | Maintains | 8 months ago |
Cellectis SaCLLS | 3 | Buy | $11.00 | +345.34% | Reiterates | 8 months ago |
Eloxx Pharmaceuticals IncELOX | 3 | Buy | $55.00 | +1,339.79% | Maintains | 9 months ago |
Gain Therapeutics IncGANX | 3 | Buy | $10.00 | +217.46% | Reiterates | 10 months ago |
Sarepta Therapeutics IncSRPT | 4 | Buy | $180.00 | +54.44% | Reiterates | a year ago |
Oncternal Therapeutics IncONCT | 2 | Buy | $180.00 | N/A | Maintains | a year ago |
United Therapeutics CorpUTHR | 2 | Buy | $375.00 | N/A | Maintains | a year ago |
Neubase Therapeutics IncNBSE | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Atyr Pharma IncLIFE | 3 | Buy | $20.00 | N/A | Maintains | 3 years ago |
F Star Therapeutics IncFSTX | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Alexion Pharmaceuticals IncALXN | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Sellas Life Sciences Group IncSLS | 1 | Buy | $650.00 | N/A | Initiates Coverage On | 5 years ago |
Arqule IncARQL | 1 | Buy | $7.00 | N/A | Initiates Coverage On | 6 years ago |
Summit Therapeutics IncSMMT | 1 | Buy | $30.00 | N/A | Maintains | 6 years ago |
Imunon IncIMNN | 1 | Buy | $9.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.